PATHOGENESIS OF PANCREATIC SOTONE : STUDIES ON THE ORGANIC MATRIX OF HUMAN PANCREATIC STONES.
胰腺结石的发病机制:人类胰腺结石有机基质的研究。
基本信息
- 批准号:05807111
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We treated pancreatic stones just after removal each from pancreatic lithiasis patients to clarify the components of the organic matrix by immunohistochemistry. Stones were fixed in 4% buffered formaldehyde for 24 hours, then decalcified stationary in 0.5N HCI with 0.1M EDTA at room temperature for up to 60 minutes. All stones were decalcified with bubble and firm sponge-like matrices were obtained. Standard staining included H-E,PAS,and alcian blue was made. Immunohistochemical staining with specific fibronectin, laminin, collagen IV,lactoferrin (DAKO), and PSP-reg antibodies were carried out by avidin-biotin complex methods. Control staining with non-immune serum was negative. Standard staining revealed that organic component formed matrix throughout the stone and matrix was heterogeneous in texture such as reticular, lamellar, and hyalin-like including altered cellular constituent. In all seven matrices, there were wide areas intensely stained for fibronectin and laminin. All specimens had positive areas for collagen IV,lactoferrin and PSP-reg, but the degree of intensity and the pattern of distribution were different in each matrix. Process of decalcification in this study is suitable for immunohistochemistry. Fragmentation of matrix occured when decalcification was carried out in EDTA with constant stirring. Organic matrix was found throughout the pancreatic stone. Lactoferrin and PSP-reg were positive in the matrix as were expected. Fibronectin, laminin and collagen IV were positive in the matrix, so extracellular matrix and basement membrane components play an important role in the pathogenesis of the pancreatic stones.
我们用免疫组织化学方法对胰腺结石患者取石后的胰腺结石进行处理,以明确有机基质的成分。石块在4%缓冲甲醛中固定24小时,然后在0.5N盐酸中用0.1M EDTA在室温下脱钙60分钟。所有的结石都用气泡脱钙,得到坚固的海绵状基质。标准染色包括H-E、PAS,并制成阿尔辛蓝。免疫组织化学染色采用抗生物素-亲和素-生物素复合体方法。非免疫血清对照染色为阴性。标准染色显示结石中的有机成分在整个结石中形成基质,基质的质地不均匀,如网状、板层状和透明质样,包括改变的细胞成分。在所有七种基质中,都有纤维连接蛋白和层粘连蛋白的广泛区域被强烈染色。所有标本均有IV型胶原、乳铁蛋白和PSP-reg的阳性区域,但强度和分布模式在每种基质中不同。本研究中的脱钙过程适用于免疫组织化学。在EDTA中持续搅拌进行脱钙时,会出现基质碎裂现象。在整个胰腺结石中发现了有机基质。不出所料,乳铁蛋白和PSP-reg在基质中呈阳性。纤维连接蛋白、层粘连蛋白和IV型胶原在胰腺结石的基质中呈阳性表达,细胞外基质和基底膜成分在胰腺结石的发病机制中起重要作用。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
NAKAMURA,RYUJI: "STUDIES ON THE PATHOGENESIS OF THE PANCREATIC STONES ; ADHESION MOLECULES,LACTOFERRIN AND PSP-reg." ANNUAL REPORT OF PANCREATIC RESERCH FOUNDATION OF JAPAN. No.1. 103-107 (1993)
NAKAMURA,RYUJI:“胰腺结石发病机制的研究;粘附分子、乳铁蛋白和 PSP-reg。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
中村隆司: "膵石形成過程と細胞接着因子、ラクトフェリン、PSP-regとの関連" 膵臓病傾向財団第1回傾向報告書. 1. 103-107 (1995)
Takashi Nakamura:“胰腺结石形成过程与细胞粘附因子、乳铁蛋白和 PSP-reg 之间的关系”胰腺疾病趋势基金会第 1 期趋势报告(1995 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKEDA Kazunori其他文献
TAKEDA Kazunori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKEDA Kazunori', 18)}}的其他基金
Realization of Neuro-Diversity by Optimisation of Reasonable Accommodation and Support Model in University
优化大学合理住宿与支持模式实现神经多样性
- 批准号:
18H03653 - 财政年份:2018
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Interdisciplinary research of reasonable accommodation on academic support for students with disabilities
残疾学生学术支持合理便利的跨学科研究
- 批准号:
26245086 - 财政年份:2014
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A study on evaluation of mental stress using non-invasive physyological measurement in psychological support of hospitalized children
无创生理测量评估住院儿童心理支持中的精神压力研究
- 批准号:
23531276 - 财政年份:2011
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The evaluation of distress using biomarkers in children with health impairment
使用生物标志物评估健康受损儿童的痛苦
- 批准号:
20530875 - 财政年份:2008
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on emotional monitoring in children with severe motor and intellectual disabilities
严重运动和智力障碍儿童情绪监测研究
- 批准号:
17530684 - 财政年份:2005
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new thrapy for severe acute pancreatitis by regulating the cannabinoid
通过调节大麻素治疗重症急性胰腺炎的新疗法
- 批准号:
13671276 - 财政年份:2001
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Chronic Pancreatitis and Its Associated Pain
间充质干细胞治疗慢性胰腺炎及其相关疼痛的安全性和有效性
- 批准号:
10721284 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Internet-Delivered Pain Self-Management to Reduce Pain and Interference in Chronic Pancreatitis
互联网提供的疼痛自我管理可减少慢性胰腺炎的疼痛和干扰
- 批准号:
10753896 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Predictive Biosignature for Endoscopic Therapy for Chronic Pancreatitis Pain
慢性胰腺炎疼痛内镜治疗的预测生物特征
- 批准号:
10794609 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Validation of peripheral CGRP signaling as a target for the treatment of pain in chronic pancreatitis
验证外周 CGRP 信号作为治疗慢性胰腺炎疼痛的靶标
- 批准号:
10764850 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Interrogating beta cell function and heterogeneity of C-peptide preservation in patients with type 1 diabetes or chronic pancreatitis
探讨 1 型糖尿病或慢性胰腺炎患者的 β 细胞功能和 C 肽保存的异质性
- 批准号:
10721566 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
A Pilot Clinical Trial of Paricalcitol for Chronic Pancreatitis
帕立骨化醇治疗慢性胰腺炎的初步临床试验
- 批准号:
10434603 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Pathophysiology of Chronic Pancreatitis Associated with Misfolded PNLIP Risk Variants
与错误折叠的 PNLIP 风险变异相关的慢性胰腺炎的病理生理学
- 批准号:
10595017 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Characterizing the fibrogenic role of NADPH oxidase 1 in the transition from chronic pancreatitis to pancreatic cancer
表征 NADPH 氧化酶 1 在慢性胰腺炎向胰腺癌转变中的纤维形成作用
- 批准号:
10515175 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Pathophysiology of Chronic Pancreatitis Associated with Misfolded PNLIP Risk Variants
与错误折叠的 PNLIP 风险变异相关的慢性胰腺炎的病理生理学
- 批准号:
10444623 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别: